New phase II result :
"This case study reports an exceptional response to 177lutetium PSMA in a patient with metastatic castration-resistant prostate cancer with DNA repair defects, including frameshift mutation in exon 11 of the BRCA2 gene."
Exceptional Response to 177-Lutetium ... - Advanced Prostate...
Exceptional Response to 177-Lutetium PSMA in Prostate Cancer Harboring DNA Repair Defects
Written by
snoraste
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
"Undetectable"
We hear the term of "undetectable" with a psa of < .1 used so often.
When I was first diagnosed...
E2 gel to fight prostate cancer.
All I ever did was to apply Oestrogel to my inner thighs, which I stopped doing years ago since my...
USPSTF Update 2024
Over 6 years later the USPSTF has yet to update the screening guidelines and we're seeing more and...
Pet scan shows stage 4
I just got diagnosis last week of prostrate cancer. My psa was 5.25. Had slight blood in pee...
Newly diagnosed Gleason 9
Hi all,
I recently had my prostate taken out and got upgraded to Gleason 9, T3b, seminal vessel...
New guidelines to prevent skeletal events in metastatic prostate cancer
MRI prior to HDR Brachy and HDR intensity.
